ScinoPharm Taiwan Ltd
TWSE:1789
ScinoPharm Taiwan Ltd
Research & Development
ScinoPharm Taiwan Ltd
Research & Development Peer Comparison
Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors
Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
ScinoPharm Taiwan Ltd
TWSE:1789
|
Research & Development
-NT$357.7m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
2%
|
|
Y
|
YungShin Global Holding Corp
TWSE:3705
|
Research & Development
-NT$314.1m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
4%
|
CAGR 10-Years
1%
|
Formosa Laboratories Inc
TWSE:4746
|
Research & Development
-NT$824.7m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-16%
|
|
S
|
SCI Pharmtech Inc
TWSE:4119
|
Research & Development
-NT$49.1m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-4%
|
Lotus Pharmaceutical Co Ltd
TWSE:1795
|
Research & Development
-NT$672.8m
|
CAGR 3-Years
-35%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
-34%
|
|
Standard Chem & Pharm Co Ltd
TWSE:1720
|
Research & Development
-NT$268.1m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-1%
|
See Also
What is ScinoPharm Taiwan Ltd's Research & Development?
Research & Development
-357.7m
TWD
Based on the financial report for Dec 31, 2023, ScinoPharm Taiwan Ltd's Research & Development amounts to -357.7m TWD.
What is ScinoPharm Taiwan Ltd's Research & Development growth rate?
Research & Development CAGR 10Y
2%
Over the last year, the Research & Development growth was -32%. The average annual Research & Development growth rates for ScinoPharm Taiwan Ltd have been -13% over the past three years , -3% over the past five years , and 2% over the past ten years .